市場調査レポート

商品コード

経皮吸収パッチの世界市場

Transdermal Patches: Global Markets

出版日: 2023年04月14日 | 発行: BCC Research

| ページ情報: 英文 262 Pages | 納期: 即納可能

価格

PDF & Excel (Single User License)

USD 5,500 861,850円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は、機能制限があるわけではありませんが、1回までとされます。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (2-5 Users)

USD 6,600 1,034,220円

レポートPDFおよびExcelを同一国内の5名迄にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は計5回までとされます。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 7,920 1,241,064円

レポートPDFおよびExcelを同一事業所に所属される方にて人数に制限なく共有ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。印刷機能に回数制限はありませんが、印刷したもののご利用はPDFのご利用者と同一範囲内です。

PDF & Excel (Enterprise License)

USD 9,504 1,489,276円

レポートPDFおよびExcelを同一企業の全ての事業所（資本100%子会社含む）にて人数に制限なく共有ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。印刷機能に回数制限はなく、同一企業内にて配布ご利用可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.70円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の経皮吸収パッチの市場規模は、2022年の67億米ドルから、予測期間中は5.6%のCAGRで推移し、2027年には88億米ドルの規模に成長すると予測されています。

疼痛緩和パッチの部門は2022年の21億米ドルから、3.6%のCAGRで推移し、2027年には25億米ドルの規模に成長すると予測されています。また、神経薬パッチの部門は、2022年の14億米ドルから、6.1%のCAGRで推移し、2027年には18億米ドルの規模に成長すると予測されています。

当レポートでは、世界の経皮吸収パッチの市場を調査し、市場および技術の概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種セグメント・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

経皮ドラッグデリバリーシステムの概要
経皮ドラッグデリバリーのメカニズム
経皮ドラッグデリバリーの利点
経皮ドラッグデリバリーの欠点
経皮ドラッグデリバリーシステムのタイプ：システムタイプ/形態別
- 経皮吸収パッチ
経皮ドラッグデリバリーシステムのタイプ：技術タイプ別
- パッシブ経皮ドラッグデリバリーシステムの各種タイプ
- アクティブ経皮ドラッグデリバリーシステム
- アクティブ経皮ドラッグデリバリーシステムの各種タイプ
経皮ドラッグデリバリー技術/システムの臨床応用分野：概要
- 疼痛管理
- 中枢神経系疾患
- ホルモン
- 禁煙
- 乗り物酔い
- 心血管疾患
- その他
疼痛管理パッチ
- 慢性疼痛の有病率
- 疼痛管理パッチの動向

第4章市場力学

市場力学
- 促進要因
- 抑制要因
- 機会

第5章製薬業界に対するCOVID-19の影響

第6章経皮吸収パッチの新技術

新興技術
- 経皮吸収型貼付剤・口腔内溶解フィルム（ODF）
- Nemaura Pharmaの経皮吸収技術

第7章世界の経皮吸収パッチ市場：製品タイプ別

ホルモンパッチ
神経薬パッチ
ニコチンパッチ
心血管関連のパッチ
鎮痛パッチ
- 市場の見通し
その他のパッチ

第8章世界の経皮吸収パッチ市場：設計別

概要
Microderm
MacroPerm
イオンパッチ

第9章世界の経皮吸収パッチ市場：技術別

第10章世界の経皮吸収パッチ市場：用途別

慢性疼痛
急性疼痛
神経疾患
ホルモン
禁煙
心血管疾患
その他

第11章世界の経皮吸収パッチ市場：地域別

北米
欧州
アジア太平洋
その他の地域

第12章競合情勢

世界の企業シェア分析

第13章企業プロファイル

ABBVIE INC.
ALVOGEN
AMNEAL PHARMACEUTICALS, INC.
BAUSCH HEALTH COMPANIES INC.
BAYER HEALTHCARE PHARMACEUTICALS
ENDO PHARMACEUTICALS INC.
GLAXOSMITHKLINE PLC
GRUNENTHAL GMBH
HISAMITSU PHARMACEUTICAL CO., INC.
ICURE PHARMA INC.
JOHNSON & JOHNSON
LAVIPHARM S. A.
LUYE PHARMA GROUP LTD.
NOVARTIS AG
PERRIGO COMPANY PLC
PURDUE PHARMA L.P.
SPARSHA PHARMA INTERNATIONAL PVT. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VIATRIS INC.

図表

List of Tables

Summary Table : Global Market for Transdermal Patches, by Product, Through 2027
Table 1 : Difference Between Topical and Transdermal Drug Delivery Systems
Table 2 : Currently Marketed Transdermal Drugs
Table 3 : Classification of Transdermal Drugs Used for Pain management
Table 4 : Products Categorized into OTC and Prescription Drugs
Table 5 : Classification of Transdermal Drugs Used for Central Nervous System Disorder Treatments
Table 6 : Classification of Transdermal Drugs Used for Motion Sickness Treatment
Table 7 : Classification of Transdermal Drugs Used for Cardiovascular Disease Treatments
Table 8 : Classification of Transdermal Drugs Used for Other Applications
Table 9 : Classification of Pain Management Patches
Table 10 : Prevalence of Chronic Pain and Percentage of Population Affected, by Country, 2018
Table 11 : Coronavirus Reported Cases and Deaths, by Country, 2020
Table 12 : Impact of COVID-19 on the Treatment of Chronic Pain
Table 13 : Recent Advances in Transdermal Drug Delivery Systems
Table 14 : Global Market for Transdermal Patches, by Product, Through 2027
Table 15 : Types of Micro Needle (MN) Patches for long-acting Contraception
Table 16 : Transdermal Patch Systems for Neurologic Conditions
Table 17 : Benefits of Transdermal Patch Designs
Table 18 : Global Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 19 : Benefits of Transdermal Patch Designs
Table 20 : Global Market for Transdermal Patches, by Design, Through 2027
Table 21 : Global Market for Transdermal Patches, by Technology, Through 2027
Table 22 : Global Market for Transdermal Patches, by Application, Through 2027
Table 23 : North American Market for Transdermal Patches, by Product, Through 2027
Table 24 : North American Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 25 : North American Market for Transdermal Patches, by Design, Through 2027
Table 26 : North American Market for Transdermal Patches, by Technology, Through 2027
Table 27 : North American Market for Transdermal Patches, by Application, Through 2027
Table 28 : North American Market for Transdermal Patches, by Country, Through 2027
Table 29 : U.S. Market for Transdermal Patches, by Product, Through 2027
Table 30 : U.S. Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 31 : U.S. Market for Transdermal Patches, by Design, Through 2027
Table 32 : U.S. Market for Transdermal Patches, by Technology, Through 2027
Table 33 : U.S. Market for Transdermal Patches, by Application, Through 2027
Table 34 : Canadian Market for Transdermal Patches, by Product, Through 2027
Table 35 : Canadian Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 36 : Canadian Market for Transdermal Patches, by Design, Through 2027
Table 37 : Canadian Market for Transdermal Patches, by Technology, Through 2027
Table 38 : Canadian Market for Transdermal Patches, by Application, Through 2027
Table 39 : Mexican Market for Transdermal Patches, by Product, Through 2027
Table 40 : Mexican Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 41 : Mexican Market for Transdermal Patches, by Design, Through 2027
Table 42 : Mexican Market for Transdermal Patches, by Technology, Through 2027
Table 43 : Mexican Market for Transdermal Patches, by Application, Through 2027
Table 44 : European Market for Transdermal Patches, by Product, Through 2027
Table 45 : European Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 46 : European Market for Transdermal Patches, by Design, Through 2027
Table 47 : European Market for Transdermal Patches, by Technology, Through 2027
Table 48 : European Market for Transdermal Patches, by Application, Through 2027
Table 49 : European Market for Transdermal Patches, by Country, Through 2027
Table 50 : German Market for Transdermal Patches, by Product, Through 2027
Table 51 : German Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 52 : German Market for Transdermal Patches, by Design, Through 2027
Table 53 : German Market for Transdermal Patches, by Technology, Through 2027
Table 54 : German Market for Transdermal Patches, by Application, Through 2027
Table 55 : Italian Market for Transdermal Patches, by Product, Through 2027
Table 56 : Italian Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 57 : Italian Market for Transdermal Patches, by Design, Through 2027
Table 58 : Italian Market for Transdermal Patches, by Technology, Through 2027
Table 59 : Italian Market for Transdermal Patches, by Application, Through 2027
Table 60 : French Market for Transdermal Patches, by Product, Through 2027
Table 61 : French Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 62 : French Market for Transdermal Patches, by Design, Through 2027
Table 63 : French Market for Transdermal Patches, by Technology, Through 2027
Table 64 : French Market for Transdermal Patches, by Application, Through 2027
Table 65 : UK Market for Transdermal Patches, by Product, Through 2027
Table 66 : UK Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 67 : UK Market for Transdermal Patches, by Design, Through 2027
Table 68 : UK Market for Transdermal Patches, by Technology, Through 2027
Table 69 : UK Market for Transdermal Patches, by Application, Through 2027
Table 70 : Spanish Market for Transdermal Patches, by Product, Through 2027
Table 71 : Spanish Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 72 : Spanish Market for Transdermal Patches, by Design, Through 2027
Table 73 : Spanish Market for Transdermal Patches, by Technology, Through 2027
Table 74 : Spanish Market for Transdermal Patches, by Application, Through 2027
Table 75 : Rest of European Market for Transdermal Patches, by Product, Through 2027
Table 76 : Rest of European Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 77 : Rest of European Market for Transdermal Patches, by Design, Through 2027
Table 78 : Rest of European Market for Transdermal Patches, by Technology, Through 2027
Table 79 : Rest of European Market for Transdermal Patches, by Application, Through 2027
Table 80 : Asia-Pacific Market for Transdermal Patches, by Product, Through 2027
Table 81 : Asia-Pacific Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 82 : Asia-Pacific Market for Transdermal Patches, by Design, Through 2027
Table 83 : Asia-Pacific Market for Transdermal Patches, by Technology, Through 2027
Table 84 : Asia-Pacific Market for Transdermal Patches, by Application, Through 2027
Table 85 : Asia-Pacific Market for Transdermal Patches, by Country, Through 2027
Table 86 : Japanese Market for Transdermal Patches, by Product, Through 2027
Table 87 : Japanese Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 88 : Japanese Market for Transdermal Patches, by Design, Through 2027
Table 89 : Japanese Market for Transdermal Patches, by Technology, Through 2027
Table 90 : Japanese Market for Transdermal Patches, by Application, Through 2027
Table 91 : Indian Market for Transdermal Patches, by Product, Through 2027
Table 92 : Indian Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 93 : Indian Market for Transdermal Patches, by Design, Through 2027
Table 94 : Indian Market for Transdermal Patches, by Technology, Through 2027
Table 95 : Indian Market for Transdermal Patches, by Application, Through 2027
Table 96 : Australian Market for Transdermal Patches, by Product, Through 2027
Table 97 : Australian Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 98 : Australian Market for Transdermal Patches, by Design, Through 2027
Table 99 : Australian Market for Transdermal Patches, by Technology, Through 2027
Table 100 : Australian Market for Transdermal Patches, by Application, Through 2027
Table 101 : Chinese Market for Transdermal Patches, by Product, Through 2027
Table 102 : Chinese Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 103 : Chinese Market for Transdermal Patches, by Design, Through 2027
Table 104 : Chinese Market for Transdermal Patches, by Technology, Through 2027
Table 105 : Chinese Market for Transdermal Patches, by Application, Through 2027
Table 106 : Rest of Asia-Pacific Market for Transdermal Patches, by Product, Through 2027
Table 107 : Rest of Asia-Pacific Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 108 : Rest of Asia-Pacific Market for Transdermal Patches, by Design, Through 2027
Table 109 : Rest of Asia-Pacific Market for Transdermal Patches, by Technology, Through 2027
Table 110 : Rest of Asia-Pacific Market for Transdermal Patches, by Application, Through 2027
Table 111 : Rest of the World Market for Transdermal Patches, by Product, Through 2027
Table 112 : Rest of the World Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 113 : Rest of the World Market for Transdermal Patches, by Design, Through 2027
Table 114 : Rest of the World Market for Transdermal Patches, by Technology, Through 2027
Table 115 : Rest of the World Market for Transdermal Patches, by Application, Through 2027
Table 116 : Rest of the World Market for Transdermal Patches, by Country, Through 2027
Table 117 : Brazilian Market for Transdermal Patches, by Product, Through 2027
Table 118 : Brazilian Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 119 : Brazilian Market for Transdermal Patches, by Design, Through 2027
Table 120 : Brazilian Market for Transdermal Patches, by Technology, Through 2027
Table 121 : Brazilian Market for Transdermal Patches, by Application, Through 2027
Table 122 : Argentinian Market for Transdermal Patches, by Product, Through 2027
Table 123 : Argentinian Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 124 : Argentinian Market for Transdermal Patches, by Design, Through 2027
Table 125 : Argentinian Market for Transdermal Patches, by Technology, Through 2027
Table 126 : Argentinian Market for Transdermal Patches, by Application, Through 2027
Table 127 : GCC Countries Market for Transdermal Patches, by Product, Through 2027
Table 128 : GCC Countries Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 129 : GCC Countries Market for Transdermal Patches, by Design, Through 2027
Table 130 : GCC Countries Market for Transdermal Patches, by Technology, Through 2027
Table 131 : GCC Countries Market for Transdermal Patches, by Application, Through 2027
Table 132 : Rest of the World Countries Market for Transdermal Patches, by Product, Through 2027
Table 133 : Rest of the World Countries Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 134 : Rest of the World Countries Market for Transdermal Patches, by Design, Through 2027
Table 135 : Rest of the World Countries Market for Transdermal Patches, by Technology, Through 2027
Table 136 : Rest of the World Countries Market for Transdermal Patches, by Application, Through 2027
Table 137 : Recent Company News, 2016-2022
Table 138 : Products, Manufacturers, and Indication
Table 139 : FDA Approved Transdermal Patches
Table 140 : AbbVie: Product Portfolio
Table 141 : AbbVie: Development & Strategy, 2022
Table 142 : Alvogen: Product Portfolio
Table 143 : Alvogen: Development & Strategy, 2020
Table 144 : Amneal Pharmaceuticals, Inc.: Product Portfolio
Table 145 : Amneal Pharmaceuticals, Inc.: Development & Strategy, 2021
Table 146 : Bausch Health Companies Inc.: Product Portfolio
Table 147 : Bausch Health Companies Inc.: Development & Strategy, 2022
Table 148 : Bayer Healthcare Pharmaceuticals: Product Portfolio
Table 149 : Bayer Healthcare Pharmaceuticals: Development & Strategy, 2018
Table 150 : Endo Pharmaceuticals Inc.: Transdermal Patches Product Portfolio
Table 151 : Endo Pharmaceuticals, Inc.: Development & Strategy, 2022
Table 152 : GlaxoSmithKline plc: Transdermal Patch Product Portfolio
Table 153 : GlaxoSmithKline: Development & Strategy, 2022
Table 154 : Grunenthal: Transdermal Patches Product Portfolio
Table 155 : Grunenthal: Development & Strategy, 2022
Table 156 : Hisamitsu Pharmaceutical Co. Inc.: Rx Product Portfolio
Table 157 : Hisamitsu Pharmaceutical Co. Inc.: OTC Pain Relief Products
Table 158 : Hisamitsu Pharmaceutical Co. Inc.: Development & Strategy, 2021
Table 159 : ICURE Pharma Inc.: Pain Management Patches Product Portfolio
Table 160 : ICURE Pharma Inc.: Development & Strategy, 2022
Table 161 : Johnson & Johnson: Transdermal Patches Product Portfolio
Table 162 : Lavipharm: Transdermal Patches Product Portfolio
Table 163 : Luye Pharma Group Ltd.: Transdermal Patches Product Portfolio
Table 164 : Novartis AG: Transdermal Patches Product Portfolio
Table 165 : Novartis AG: Development & Strategy, 2022
Table 166 : Perrigo Company plc: Transdermal Drug Delivery Product Portfolio
Table 167 : Purdue Pharma L.P.: Transdermal Patches Product Portfolio
Table 168 : Sparsha Pharma International Pvt. Ltd.: Pain Management Patches Product Portfolio
Table 169 : Sparsha Pharma International Pvt. Ltd: Development & Strategy, 2022
Table 170 : Teva Pharmaceutical Industries Ltd.: Transdermal Patches Product Portfolio
Table 171 : Teva Pharmaceutical Industries Ltd.: Development & Strategy, 2022
Table 172 : Viatris Inc.: Transdermal Patches Product Portfolio
Table 173 : Viatris Inc.: Development & Strategy, 2022
Table 174 : List of Companies Certified as Innovative Pharmaceutical Companies in Korea

List of Figures

Summary Figure : Global Market Shares of Transdermal Patches, by Product, 2021
Figure 1 : Mechanism of Transdermal Drug Delivery System
Figure 2 : Single Layer Drug in Adhesive Transdermal Delivery System
Figure 3 : Multi-layer Drug in Adhesive Transdermal Delivery System
Figure 4 : Matrix Transdermal Delivery System
Figure 5 : Reservoir Transdermal Delivery System
Figure 6 : Prevalence of Pain at Different Sites of the Body, 2014
Figure 7 : Global 60+ Population, by Region, 2015-2050
Figure 8 : Prevalence Rates of Chronic Pain in Different Age Groups, 2023
Figure 9 : Global Projected Diabetes, Patients Aged 20-79, 2010 and 2030
Figure 10 : Percentage of Population Affected by Chronic Pain, 2018
Figure 11 : Identified Non-opioid Drug Distribution, by Indication, 2018
Figure 12 : Korea Pharmaceutical Industry Development Strategy
Figure 13 : Impact of COVID-19 on Pharma Industry
Figure 14 : Snapshot of Major Products in the TAHO pipeline
Figure 15 : Global Market Shares of Transdermal Patches, by Product, 2021
Figure 16 : Global Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 17 : Global Market Shares of Transdermal Patches, by Design, 2021
Figure 18 : Global Market Shares of Transdermal Patches, by Technology, 2021
Figure 19 : Global Market Shares for Transdermal Patches, by Application, 2021
Figure 20 : North American Market Shares of Transdermal Patches, by Product, 2021
Figure 21 : North American Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 22 : North American Market Shares of Transdermal Patches, by Design, 2021
Figure 23 : North American Market Shares of Transdermal Patches, by Technology, 2021
Figure 24 : North American Market Shares of Transdermal Patches, by Application, 2021
Figure 25 : North American Market Shares of Transdermal Patches, by Country, 2021
Figure 26 : U.S. Market Shares of Transdermal Patches, by Product, 2021
Figure 27 : U.S. Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 28 : U.S. Market Shares of Transdermal Patches, by Design, 2021
Figure 29 : U.S. Market Shares of Transdermal Patches, by Technology, 2021
Figure 30 : U.S. Market Shares of Transdermal Patches, by Application, 2021
Figure 31 : 65+ U.S. Population, 2010-2050
Figure 32 : Canadian Market Shares of Transdermal Patches, by Product, 2021
Figure 33 : Canadian Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 34 : Canadian Market Shares of Transdermal Patches, by Design, 2021
Figure 35 : Canadian Market Shares of Transdermal Patches, by Technology, 2021
Figure 36 : Canadian Market Shares of Transdermal Patches, by Application, 2021
Figure 37 : Canadian Cancer Statistics, 2022
Figure 38 : Mexican Market Shares of Transdermal Patches, by Product, 2021
Figure 39 : Mexican Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 40 : Mexican Market Shares of Transdermal Patches, by Design, 2021
Figure 41 : Mexican Market Shares of Transdermal Patches, by Technology, 2021
Figure 42 : Mexican Market Shares of Transdermal Patches, by Application, 2021
Figure 43 : European Market Shares of Transdermal Patches, by Product, 2021
Figure 44 : European Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 45 : European Market Shares of Transdermal Patches, by Design, 2021
Figure 46 : European Market Shares of Transdermal Patches, by Technology, 2021
Figure 47 : European Market Shares of Transdermal Patches, by Application, 2021
Figure 48 : European Market Shares of Transdermal Patches, by Country, 2021
Figure 49 : German Market Shares of Transdermal Patches, by Product, 2021
Figure 50 : German Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 51 : German Market Shares of Transdermal Patches, by Design, 2021
Figure 52 : German Market Shares of Transdermal Patches, by Technology, 2021
Figure 53 : German Market Shares of Transdermal Patches, by Application, 2021
Figure 54 : Italian Market Shares of Transdermal Patches, by Product, 2021
Figure 55 : Italian Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 56 : Italian Market Shares of Transdermal Patches, by Design, 2021
Figure 57 : Italian Market Shares of Transdermal Patches, by Technology, 2021
Figure 58 : Italian Market Shares of Transdermal Patches, by Application, 2021
Figure 59 : French Market Shares of Transdermal Patches, by Product, 2021
Figure 60 : French Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 61 : French Market Shares of Transdermal Patches, by Design, 2021
Figure 62 : French Market Shares of Transdermal Patches, by Technology, 2021
Figure 63 : French Market Shares of Transdermal Patches, by Application, 2021
Figure 64 : UK Market Shares of Transdermal Patches, by Product, 2021
Figure 65 : UK Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 66 : UK Market Shares of Transdermal Patches, by Design, 2021
Figure 67 : UK Market Shares of Transdermal Patches, by Technology, 2021
Figure 68 : UK Market Shares of Transdermal Patches, by Application, 2021
Figure 69 : Spanish Market Shares of Transdermal Patches, by Product, 2021
Figure 70 : Spanish Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 71 : Spanish Market Shares of Transdermal Patches, by Design, 2021
Figure 72 : Spanish Market Shares of Transdermal Patches, by Technology, 2021
Figure 73 : Spanish Market Shares of Transdermal Patches, by Application, 2021
Figure 74 : Rest of European Market Shares of Transdermal Patches, by Product, 2021
Figure 75 : Rest of European Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 76 : Rest of European Market Shares of Transdermal Patches, by Design, 2021
Figure 77 : Rest of European Market Shares of Transdermal Patches, by Technology, 2021
Figure 78 : Rest of European Market Shares of Transdermal Patches, by Application, 2021
Figure 79 : Asia-Pacific Market Shares of Transdermal Patches, by Product, 2021
Figure 80 : Asia-Pacific Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 81 : Asia-Pacific Market Shares of Transdermal Patches, by Design, 2021
Figure 82 : Asia-Pacific Market Shares of Transdermal Patches, by Technology, 2021
Figure 83 : Asia-Pacific Market Shares of Transdermal Patches, by Application, 2021
Figure 84 : Asia-Pacific Market Shares of Transdermal Patches, by Country, 2021
Figure 85 : Japanese Market Shares of Transdermal Patches, by Product, 2021
Figure 86 : Japanese Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 87 : Japanese Market Shares of Transdermal Patches, by Design, 2021
Figure 88 : Japanese Market Shares of Transdermal Patches, by Technology, 2021
Figure 89 : Japanese Market Shares of Transdermal Patches, by Application, 2021
Figure 90 : Indian Market Shares of Transdermal Patches, by Product, 2021
Figure 91 : Indian Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 92 : Indian Market Shares of Transdermal Patches, by Design, 2021
Figure 93 : Indian Market Shares of Transdermal Patches, by Technology, 2021
Figure 94 : Indian Market Shares of Transdermal Patches, by Application, 2021
Figure 95 : Australian Market Shares of Transdermal Patches, by Product, 2021
Figure 96 : Australian Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 97 : Australian Market Shares of Transdermal Patches, by Design, 2021
Figure 98 : Australian Market Shares of Transdermal Patches, by Technology, 2021
Figure 99 : Australian Market Shares of Transdermal Patches, by Application, 2021
Figure 100 : Chinese Market Shares of Transdermal Patches, by Product, 2021
Figure 101 : Chinese Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 102 : Chinese Market Shares of Transdermal Patches, by Design, 2021
Figure 103 : Chinese Market Shares of Transdermal Patches, by Technology, 2021
Figure 104 : Chinese Market Shares of Transdermal Patches, by Application, 2021
Figure 105 : Rest of Asia-Pacific Market Shares of Transdermal Patches, by Product, 2021
Figure 106 : Rest of Asia-Pacific Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 107 : Rest of Asia-Pacific Market Shares of Transdermal Patches, by Design, 2021
Figure 108 : Rest of Asia-Pacific Market Shares of Transdermal Patches, by Technology, 2021
Figure 109 : Rest of Asia-Pacific Market Shares of Transdermal Patches, by Application, 2021
Figure 110 : Rest of the World Market Shares of Transdermal Patches, by Product, 2021
Figure 111 : Rest of the World Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 112 : Rest of the World Market Shares of Transdermal Patches, by Design, 2021
Figure 113 : Rest of the World Market Shares of Transdermal Patches, by Technology, 2021
Figure 114 : Rest of the World Market Shares of Transdermal Patches, by Application, 2021
Figure 115 : Rest of the World Market Shares of Transdermal Patches, by Country, 2021
Figure 116 : Brazilian Market Shares of Transdermal Patches, by Product, 2021
Figure 117 : Brazilian Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 118 : Brazilian Market Shares of Transdermal Patches, by Design, 2021
Figure 119 : Brazilian Market Shares of Transdermal Patches, by Technology, 2021
Figure 120 : Brazilian Market Shares of Transdermal Patches, by Application, 2021
Figure 121 : Argentinian Market Shares of Transdermal Patches, by Product, 2021
Figure 122 : Argentinian Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 123 : Argentinian Market Shares of Transdermal Patches, by Design, 2021
Figure 124 : Argentinian Market Shares of Transdermal Patches, by Technology, 2021
Figure 125 : Argentinian Market Shares of Transdermal Patches, by Application, 2021
Figure 126 : GCC Countries Market Shares of Transdermal Patches, by Product, 2021
Figure 127 : GCC Countries Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 128 : GCC Countries Market Shares of Transdermal Patches, by Design, 2021
Figure 129 : GCC Countries Market Shares of Transdermal Patches, by Technology, 2021
Figure 130 : GCC Countries Market Shares of Transdermal Patches, by Application, 2021
Figure 131 : Rest of the World Countries Market Shares of Transdermal Patches, by Product, 2021
Figure 132 : Rest of the World Countries Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 133 : Rest of the World Countries Market Shares of Transdermal Patches, by Design, 2021
Figure 134 : Rest of the World Countries Market Shares of Transdermal Patches, by Technology, 2021
Figure 135 : Rest of the World Countries Market Shares of Transdermal Patches, by Application, 2021
Figure 136 : Global Market Shares of Transdermal Patches, by Company, 2021
Figure 137 : AbbVie: Financial Performance, 2019-2021
Figure 138 : AbbVie: Revenue Share, by Region, 2021
Figure 139 : Bausch Health Companies Inc.: Financial Performance, 2020 and 2021
Figure 140 : Bausch Health Companies Inc.: Revenue Share, by Segment, 2021
Figure 141 : Bayer Healthcare Pharmaceuticals: Financial Performance, 2020 and 2021
Figure 142 : Endo Pharmaceuticals Inc.: Annual Revenue, 2016-2021
Figure 143 : Endo Pharmaceuticals Inc.: Revenue Share, by Established Product, 2019
Figure 144 : GlaxoSmithKline plc: Annual Revenue, 2017-2021
Figure 145 : GlaxoSmithKline plc: Revenue Share, by Consumer Healthcare, 2019
Figure 146 : Grunenthal: Annual Revenue, 2018-2022
Figure 147 : Hisamitsu Pharmaceutical Co. Inc.: Annual Revenue, 2018-2022
Figure 148 : ICURE Pharma Inc.: Annual Revenue, 2018-2021
Figure 149 : Johnson & Johnson: Annual Revenue, 2016-2021
Figure 150 : Novartis AG: Annual Revenue, 2015-2019
Figure 151 : Teva Pharmaceutical Industries Ltd.: Generic Segment Annual Revenue, 2016-2021
Figure 152 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2019
Figure 153 : Viatris Inc.: Annual Revenue, 2020-2022

Product Code: PHM273A

Highlights:

The global market for transdermal patches is estimated to increase from $6.7 billion in 2022 to reach $8.8 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.

Pain relief patches market for transdermal patches is estimated to increase from $2.1 billion in 2022 to reach $2.5 billion by 2027, at a CAGR of 3.6% from 2022through 2027.

Neuro drug patches market for transdermal patches is estimated to increase from $1.4 billion in 2022 to reach $1.8 billion by 2027, at a CAGR of 6.1% from 2022 through 2027.

Report Scope:

This report aims to provide a comprehensive study of the global market for transdermal patches. It provides a detailed description of the different types of transdermal patch products and technology, as well as their current and historical market revenues.

Transdermal patches can be separated by their differing designs and technology, along with their applications. Transdermal patch technologies include matrix, reservoir, and other transdermal drug delivery technologies/systems.

This report also covers a detailed study of therapeutic applications of transdermal drug delivery, including pain, central nervous system disorders, hormonal applications, smoking cessation, motion sickness, cardiovascular disorders, and others. This in-depth analysis of the global market for transdermal patches includes historical data and market projections for sales segment by technology/system type, product, application, design, and region.

For in-depth understanding of the market, profiles of market participants, key marketed products, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses driving and restraining factors of the global transdermal drug delivery technologies/devices market.

Report Includes:

122 data tables and 53 additional tables
An overview of the global transdermal patches market
Estimation of the market size and analyses of global market trends, with data from 2019-2022, with projections of compound annual growth rates (CAGRs) through 2027
Highlights of the current and future market potential and quantification of transdermal patches market based on type, design, technology, application, and region
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
Analysis of transdermal patches pipeline products with focus on promising pipeline molecules/ drugs in development, and coverage of technological advances, scientific discoveries, and new therapies
Detailed analysis of the regulatory framework and policies, and snapshot of transdermal drug delivery system
Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
Comprehensive company profiles of the leading players of the industry, including GlaxoSmithKline, Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan Pharmaceuticals inc. (Viatris), Novartis and Teva Pharmaceutical Industries Ltd.

Chapter 1 Introduction

1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 Scope of Report
1.4 Information Sources
1.5 Methodology
1.6 Geographic Breakdown
1.7 Analyst's Credentials
1.8 BCC Custom Research
1.9 Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

3.1 Overview of Transdermal Drug Delivery Systems
3.2 Mechanism of Transdermal Drug Delivery
3.3 Advantages of Transdermal Drug Delivery
3.4 Disadvantages of Transdermal Drug Delivery
3.5 Types of Transdermal Drug Delivery Systems Based on System Types/Forms
- 3.5.1 Transdermal Patch
3.6 Types of Transdermal Drug Delivery Systems Based on Technology Types
- 3.6.1 Types of Passive Transdermal Drug Delivery Systems
- 3.6.2 Active Transdermal Drug Delivery Systems
- 3.6.3 Types of Active Transdermal Drug Delivery System
3.4 Overview of Clinical Application Areas of Transdermal Drug Delivery Technologies/Systems
- 3.4.1 Pain Management
- 3.4.2 Central Nervous System Disorders
- 3.4.3 Hormonal Applications
- 3.4.4 Smoking Cessation
- 3.4.5 Motion Sickness
- 3.4.6 Cardiovascular Diseases
- 3.4.7 Others
3.5 Pain Management Patches
- 3.5.1 Prevalence of Chronic Pain
- 3.5.2 Trends in Pain Management Patches

Chapter 4 Market Dynamics

4.1 Market Dynamics
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities

Chapter 5 Impact of COVID-19 on Pharma Industry

5.1 Overview
5.2 Short-term Impact on the Pharma Industry
5.3 Long-term Impact on the Pharma Industry
5.4 COVID-19 and Pain Management
- 5.4.1 Telemedicine

Chapter 6 Emerging Technology in Transdermal Patches

6.1 Emerging Technology
- 6.1.1 Transdermal Patches and Orally Dissolving Film (ODF)
- 6.1.2 Nemaura Pharma Transdermal Technology

Chapter 7 Global Market for Transdermal Patches by Product Type

7.1 Introduction
7.2 Hormonal Patches
7.3 Neuro Drug Patches
7.4 Nicotine Patches
7.5 Cardiac and Blood-related Patches
7.6 Pain Relief Patches
- 7.6.1 Market Outlook
7.7 Other Patches

Chapter 8 Global Market for Transdermal Patches by Design

8.1 Overview
8.2 Microderm
8.3 Macroperm
8.4 IontoPatch

Chapter 9 Global Market for Transdermal Patches by Technology

9.1 Global Market for Transdermal Patches by Technology

Chapter 10 Global Market for Transdermal Patches by Application

10.1 Global Market for Transdermal Patches by Application
10.2 Chronic Pain
10.3 Acute Pain
10.4 Neural Diseases
10.5 Hormonal Applications
10.6 Smoking Cessation
10.7 Cardiac and Blood Diseases
10.8 Other Applications

Chapter 11 Global Market for Transdermal Patches by Region

11.1 Global Markets for Transdermal Patches by Region
11.2 North America
- 11.2.1 United States
- 11.2.2 Canada
- 11.2.3 Mexico
11.3 Europe
- 11.3.1 Germany
- 11.3.2 Italy
- 11.3.3 France
- 11.3.4 United Kingdom
- 11.3.5 Spain
- 11.3.6 Rest of Europe
11.4 Asia-Pacific
- 11.4.1 Japan
- 11.4.2 India
- 11.4.3 Australia
- 11.4.4 China
- 11.4.5 Rest of Asia-Pacific
11.5 Rest of the World
- 11.5.1 Brazil
- 11.5.2 Argentina
- 11.5.3 GCC Countries
- 11.5.4 Rest of the World Countries

Chapter 12 Competitive Landscape

12.1 Global Analysis of Company Shares

Chapter 13 Company Profiles

ABBVIE INC.
ALVOGEN
AMNEAL PHARMACEUTICALS, INC.
BAUSCH HEALTH COMPANIES INC.
BAYER HEALTHCARE PHARMACEUTICALS
ENDO PHARMACEUTICALS INC.
GLAXOSMITHKLINE PLC
GRUNENTHAL GMBH
HISAMITSU PHARMACEUTICAL CO., INC.
ICURE PHARMA INC.
JOHNSON & JOHNSON
LAVIPHARM S. A.
LUYE PHARMA GROUP LTD.
NOVARTIS AG
PERRIGO COMPANY PLC
PURDUE PHARMA L.P.
SPARSHA PHARMA INTERNATIONAL PVT. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VIATRIS INC.

経皮吸収パッチの世界市場

Transdermal Patches: Global Markets

目次

第1章イントロダクション

第2章サマリー・ハイライト

第3章市場概要

第4章市場力学

第5章製薬業界に対するCOVID-19の影響

第6章経皮吸収パッチの新技術

第7章世界の経皮吸収パッチ市場：製品タイプ別

第8章世界の経皮吸収パッチ市場：設計別

第9章世界の経皮吸収パッチ市場：技術別

第10章世界の経皮吸収パッチ市場：用途別

第11章世界の経皮吸収パッチ市場：地域別

第12章競合情勢

第13章企業プロファイル

List of Tables

List of Figures

Highlights:

Report Scope:

Report Includes:

Table of Contents

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

Chapter 4 Market Dynamics

Chapter 5 Impact of COVID-19 on Pharma Industry

Chapter 6 Emerging Technology in Transdermal Patches

Chapter 7 Global Market for Transdermal Patches by Product Type

Chapter 8 Global Market for Transdermal Patches by Design

Chapter 9 Global Market for Transdermal Patches by Technology

Chapter 10 Global Market for Transdermal Patches by Application

Chapter 11 Global Market for Transdermal Patches by Region

Chapter 12 Competitive Landscape

Chapter 13 Company Profiles

経皮吸収パッチの世界市場

Transdermal Patches: Global Markets

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場概要

第4章 市場力学

第5章 製薬業界に対するCOVID-19の影響

第6章 経皮吸収パッチの新技術

第7章 世界の経皮吸収パッチ市場：製品タイプ別

第8章 世界の経皮吸収パッチ市場：設計別

第9章 世界の経皮吸収パッチ市場：技術別

第10章 世界の経皮吸収パッチ市場：用途別

第11章 世界の経皮吸収パッチ市場：地域別

第12章 競合情勢

第13章 企業プロファイル

List of Tables

List of Figures

Highlights:

Report Scope:

Report Includes:

Table of Contents

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

Chapter 4 Market Dynamics

Chapter 5 Impact of COVID-19 on Pharma Industry

Chapter 6 Emerging Technology in Transdermal Patches

Chapter 7 Global Market for Transdermal Patches by Product Type

Chapter 8 Global Market for Transdermal Patches by Design

Chapter 9 Global Market for Transdermal Patches by Technology

Chapter 10 Global Market for Transdermal Patches by Application

Chapter 11 Global Market for Transdermal Patches by Region

Chapter 12 Competitive Landscape

Chapter 13 Company Profiles

第1章イントロダクション

第2章サマリー・ハイライト

第3章市場概要

第4章市場力学

第5章製薬業界に対するCOVID-19の影響

第6章経皮吸収パッチの新技術

第7章世界の経皮吸収パッチ市場：製品タイプ別

第8章世界の経皮吸収パッチ市場：設計別

第9章世界の経皮吸収パッチ市場：技術別

第10章世界の経皮吸収パッチ市場：用途別

第11章世界の経皮吸収パッチ市場：地域別

第12章競合情勢

第13章企業プロファイル